A Mono centric, Double Blind, Randomized, Placebo controlled Sequential Phase-I Study to Evaluate Safety, Tolerability and Pharmacokinetics of Nasal Spray of Tapentadol HCl (Torrent Pharmaceuticals Ltd., India) following Single and Multiple Ascending Doses in Healthy Human Volunteers.

Trial Profile

A Mono centric, Double Blind, Randomized, Placebo controlled Sequential Phase-I Study to Evaluate Safety, Tolerability and Pharmacokinetics of Nasal Spray of Tapentadol HCl (Torrent Pharmaceuticals Ltd., India) following Single and Multiple Ascending Doses in Healthy Human Volunteers.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Feb 2017

At a glance

  • Drugs Tapentadol (Primary)
  • Indications Pain
  • Focus Adverse reactions
  • Sponsors Torrent Pharmaceuticals
  • Most Recent Events

    • 26 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top